Scholars Central

Research articlePublished 2013

Safety and Immunogenicity of ETHIORAB Rabies Vaccine

Authors: Birhanu Hurisa, Belete Tegbaru, Dagmar Nolkes, Abebe Mengesha, Gezahegn Kebede, Sisay Kerga, Amdemicael Adhanom, Alemayehu Godana, Dereje Nigussie, Bethelehem Newayesilasie, Gashaw Gebrewold, Denis Bankovskiy, Artem Metlin, Kelbessa Urga

Journal of Vaccines & Vaccination

Volume 4 · Issue 6 · Pages 1–5

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Worldwide rabies in dogs is the source of 99% of human infections. This makes dogs potential reservoir and transmitters to human being. Pre and post-exposure prophylaxis are means of protection against the rabies virus. The main objective of this experiment was to determine the safety and immunogenicity of Vero cell culture based rabies vaccine “ETHIORAB” manufactured by Ethiopian Health and Nutrition Research Institute, Vaccine and Diagnostic Production Directorate. The obtained vaccine was tested on mice and satisfactory safety results were observed. Random Clinical Trial (RCT) design was used for this experiment. Twelve experimental dogs from local breed were duly conditioned during a quarantine period and assigned to two groups randomly. Group I (cases) were vaccinated subcutaneously with 1 ml of ETHIORAB. Dogs in group II served as non-vaccinated controls. To evaluate the titer of the rabies virus neutralizing antibodies (VNA), sera were analyzed by Fluorescent Antibody Virus Neutralization (FAVN) test. Serum neutralizing antibody geomtric mean titers (GMT) to rabies virus was determined at days 7, 15, 21, 30, 60 and 90. Geomtric mean titers were equal to 1.55, 1.73, 2.02, 3.45, 3.57 and 3.17 IU/ml respectively. All dogs showed VNA titers higher than the 0.5 IU/ml mandated WHO recommended threshold. This study indicated ETHIORAB rabies vaccine manufactured in Ethiopia is safe and immunogenic.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Vaccines & Vaccination
  • SubjectVaccines & Immunisation
  • BylineArticles whose byline prints “Birhanu Hurisa”
  • BylineArticles whose byline prints “Belete Tegbaru”
  • BylineArticles whose byline prints “Dagmar Nolkes”
  • BylineArticles whose byline prints “Abebe Mengesha”
  • BylineArticles whose byline prints “Gezahegn Kebede”
  • BylineArticles whose byline prints “Sisay Kerga”
  • BylineArticles whose byline prints “Amdemicael Adhanom”
  • BylineArticles whose byline prints “Alemayehu Godana”